Share Success: Letters From Readers
I: From Anonymous
Submit Form on Thursday, November 27, 2014 at 23:24:05
I started taking EZorb several yrs ago because of osteoporosis, which I was told was severe.
After taking Actonel for only a couple of months, I had such a severe reaction to it, that I
almost died! After taking the EZorb, I no longer ache all over and don't need to see my chiropractor as often!
I don't want to go for another BD scan as I am now scared of doctors, but I know I'm better because of the way I feel and I credit EZorb. I've also fallen twice and no fractures or broken bones, which is one of the scare tactics doctors used on me so successfully!
II: From Donna F.
Submit Form on Thursday, August 28, 2014 at 14:59:17
Hi, My name is Donna F. I have been taking ezorb for the past 9 years. I have osteo. Naturally my doctor wanted to prescribe me with Fosamax. I said no, quickly went looking for a better alternative.
My 2nd bone density showed an improvement, but my Dr. still tried to get me to take other types of drugs. I still said no.
I have way more energy, strong nails and ezorb is working for me. Some Doctors really like to just hand out the pills.
About 6 months ago I fell down a flight of stairs. I hit almost every step on my back and
hurt my wrist. It was a really bad fall. I had xrays taken on my wrist. I kept being told that I am really boney in my fingers and wrist. Well I weigh 105 pounds. I'm not sure why I was even told that. It took awhile, but if it wasn't for ezorb I don't know where I would of been.
My wrist is better and I still have a bit of problems on my lower back. I am planning to go for another bone density test soon. I believe in ezorb and think it has helped me out a great deal. By the way, from the horrible fall, NO BROKEN BONES.
III: From Don D.
Submit Form on Tuesday, July 15, 2014 at 15:41:22
I have been taking Ezorb for about 5 weeks for a bone spur in my right heel. Started with 2 caps 3 times per day for about 1 week. Then went to 4 caps 3 time daily.
Now at approx. 5 weeks have noticed much relief. Not 100% yet but can usually do my daily routine without too much discomfort.
the Desk of EZorb Newsletter Editor:
newsletter is now read by over 70,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public.
Research News: Guidelines for Treating Small Renal Masses Questioned
Partial nephrectomy (PN) and percutaneous ablation for small and localized renal masses produce similar rates of local tumor recurrence, report US researchers.
They say these data suggest there should be an update to the American Urological Association's guidelines for renal masses, which recommends that PN should be strongly considered for healthy patients with cT1a renal masses and should be discussed as an alternate standard for cT1b patients.
Led by Robert Houston Thompson (Mayo Clinic, Rochester, Minnesota, USA) the group compared local recurrence-free, metastases-free, and overall survival among patients treated with PN, percutaneous radiofrequency ablation (RFA), and percutaneous cryoablation for sporadic and localized solid renal masses.
Of the 1803 patients included in the study, 1424 had cT1a tumors and 379 had cT1b tumors. For patients with cT1a renal masses, 1057 underwent PN, 180 underwent RFA, and 187 underwent cryoablation.
The researchers observed that recurrence-free survival was similar among the three treatment groups at 3 years, whereas metastases-free survival was inferior for RFA compared with the other treatments, and overall survival was superior for PN.
Of the cT1b patients, 326 underwent PN and 53 patients were managed with cryoablation. Eight patients underwent RFA but were excluded from the final analysis.
The researchers found that recurrence-free survival and metastases-free survival were similar for PN and cryoablation patients, while overall survival again favored PN patients. However Thompson et al note that this is likely reflective of selection bias.
"To our knowledge, these results represent the first comparison of oncologic outcomes among PN, percutaneous RFA, and percutaneous cryoablation patients at a single center with extensive experience in each technique", they write in European Urology.
"In a large cohort of sporadic cT1 renal masses, we observed that recurrence-free survival was similar for PN and percutaneous ablation patients."
The team concludes: "If validated, these data suggest that an update to clinical guidelines would be warranted."
Original research was published in Eur Urol 2014; Advance online publication.
Asked Questions & Answers
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix.